Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Clinical trial NCT04952766 · COMPLETED

Trial details

NCT number: NCT04952766
Sponsor: Centre Hospitalier Régional d'Orléans
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant Myeloma Cancer Hematologic Malignancy Multiple Sclerosis Hypergammaglobulinemia Malignant Tumor Hiv Diabetes Type 2

Start date: 2021-03-26
Primary completion: 2022-02-06
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.